Opioids Treatment Maker Indivior Pleads Guilty, Will Pay $600M
SLOUGH, England — Drug maker Indivior PLC on July 24 announced that it has agreed to resolve a federal charge and regulatory investigation into false statements about its opioids treatment Suboxone...To view the full article, register now.
Already a subscriber? Click here to view full article